Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Mucosal Immunology
|
October 24, 2019
Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps
Noriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
The Journal of Allergy and Clinical Immunology
|
April 5, 2021
Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis
Whitney W Stevens, Anna G Staudacher, Kathryn E Hulse, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 13, 2018
Short-chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43
Y Imoto, A Kato, T Takabayashi, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 13, 2015
Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease
Whitney W Stevens, Christopher J Ocampo, Sergejs Berdnikovs, et al.
Immunity, Inflammation and Disease
|
May 6, 2017
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps
Julie A Poposki, Aiko I Klingler, Bruce K Tan, et al.
The Journal of Allergy and Clinical Immunology
|
October 28, 2017
IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells
Noriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 22, 2016
Chronic airway inflammation provides a unique environment for B cell activation and antibody production
S Feldman, R Kasjanski, J Poposki, et al.
The Journal of Allergy and Clinical Immunology
|
April 5, 2015
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease
Kathryn L Pothoven, James E Norton, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology
|
May 7, 2020
Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease
Whitney W Stevens, Anna G Staudacher, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2016
Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis
Griet A Van Roey, Christopher C Vanison, Jeffanie Wu, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Mucosal Immunology
|
October 24, 2019
Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps
Noriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
The Journal of Allergy and Clinical Immunology
|
April 5, 2021
Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis
Whitney W Stevens, Anna G Staudacher, Kathryn E Hulse, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 13, 2018
Short-chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43
Y Imoto, A Kato, T Takabayashi, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 13, 2015
Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease
Whitney W Stevens, Christopher J Ocampo, Sergejs Berdnikovs, et al.
Immunity, Inflammation and Disease
|
May 6, 2017
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps
Julie A Poposki, Aiko I Klingler, Bruce K Tan, et al.
The Journal of Allergy and Clinical Immunology
|
October 28, 2017
IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells
Noriko Ogasawara, Julie A Poposki, Aiko I Klingler, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 22, 2016
Chronic airway inflammation provides a unique environment for B cell activation and antibody production
S Feldman, R Kasjanski, J Poposki, et al.
The Journal of Allergy and Clinical Immunology
|
April 5, 2015
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease
Kathryn L Pothoven, James E Norton, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology
|
May 7, 2020
Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease
Whitney W Stevens, Anna G Staudacher, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2016
Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis
Griet A Van Roey, Christopher C Vanison, Jeffanie Wu, et al.
Page
of 11